This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Systematic search conducted without language restrictions from December 1, 2019 to June 31, 2022 on PubMed, EMBASE, Web of Science, Cochrane library, ProQuest Coronavirus Research Database, COVID-19 Living Overview of the Evidence (L-OVE) subset of Episteminokos and the World Health Organization (WHO) Covid-19 databases.
COVID-19 is a respiratory disease primarily affecting the lungs. However, the SARS-CoV-2 virus that causes COVID-19 surprised doctors and scientists by causing an unusually large percentage of patients to experience vascular complicationsissues related to blood flow, such as blood clots, heart attacks, and strokes.
Moderate to severe anemia was linked to an increase in cardiac arrest or stroke compared with normal hemoglobin levels in critically ill COVID-19 patients.
A large international research collaboration, led by an academic from Royal Holloway, University of London, found that blood groups could help predict the risk of venous strokes associated with the Oxford-AstraZeneca COVID-19 vaccine.
For Medicare beneficiaries aged 65 years and older, there is no evidence of elevated stroke risk immediately after vaccination with either brand of the COVID-19 bivalent vaccine, according to a study published in the March 19 issue of the Journal of the American Medical Association.
(MedPage Today) -- Investigation of an early signal for stroke associated with COVID-19 bivalent vaccines turned into suspicion of high-dose or adjuvanted flu shots instead, based on a large U.S. population-based study. When researchers inspected.
The proposed imaging system can diagnose diabetes, stroke, anemia, asthma, liver and gallbladder conditions, COVID-19, and a range of vascular and gastrointestinal issues, according to new research. A computer algorithm has achieved a 98% accuracy in predicting different diseases by analyzing the color of the human tongue.
This study compares sleep duration and stroke risk between residents of China and the U.S. during and outside the COVID-19 pandemic, examining age as an interaction effect.
In this weeks View, Dr. Eagle looks at left atrial appendage occlusion for stroke prevention in patients with AFib. Finally, Dr. Eagle explores anticoagulation for patients who are hospitalized with COVID-19. He then discusses a new treatment for severe hypertrophic cardiomyopathy in children.
Stroke, Volume 56, Issue Suppl_1 , Page AWP268-AWP268, February 1, 2025. Introduction:The overall composition of stroke subtype is typically stable within biogeographical groups. Whether the COVID-19 pandemic impacted stroke etiology is still being investigated, but most studies have been performed outside the United States.
Stroke, Volume 55, Issue 1 , Page 78-88, January 1, 2024. BACKGROUND:The association of COVID-19 with higher bleeding risk and worse outcomes in acute ischemic stroke (AIS) undergoing revascularization may be related to the presence of infection symptoms. 1.51]; S-COVID, 2.10 [95% CI, 1.75–2.53]). versus 85.6%;P<0.001),
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionIn Latin America and the Caribbean, stroke is the second greatest cause of both mortality and disability, with different incidence and prevalence rates across the regions due to regional and socioeconomic factors (Camargo et al.,
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionThe goal of this research project is to investigate the impacts and effects of the COVID‐19 pandemic on acute ischemic stroke treatment in North America.
BackgroundPatients with ischemic stroke and concomitant COVID‐19 infection have worse outcomes than those without this infection, but the impact of COVID‐19 on hemorrhagic stroke remains unclear. We aimed to assess if COVID‐19 worsens outcomes in intracerebral hemorrhage (ICH).Methods
Stroke, Volume 55, Issue Suppl_1 , Page ATP34-ATP34, February 1, 2024. Background:Hemorrhagic cerebrovascular manifestations are known to be associated with COVID-19. Comparative outcome analyses between pre-COVID (2016-2019) and COVID year (2020) were performed. revealing an increase from pre-COVID 3.3
Stroke, Volume 56, Issue Suppl_1 , Page A162-A162, February 1, 2025. Background:Preceding respiratory tract infections (RTIs) caused by bacteria or viruses are associated with worse stroke outcomes, likely due to an exaggerated inflammatory immune response, endothelial dysfunction, platelet activation, and coagulopathy. On day 6 (S.
Stroke, Volume 55, Issue Suppl_1 , Page ATP180-ATP180, February 1, 2024. Background:Coronavirus disease 2019 (COVID-19) increases the risk of cerebral venous sinus thrombosis (CVST), and previous reports derived from small case series reported a high mortality in these patients, up to 40%.
Stroke, Volume 55, Issue Suppl_1 , Page AWP324-AWP324, February 1, 2024. COVID-19 neurological complications such as strokes and cognitive impairment have been reported. A mild and reproducible thromboembolic model will be a helpful tool for investigating COVID-thromboembolic complications.
International Stroke Conference 2024 to Present High-Profile Late-Breaking Science 6. Chung-Ang University Study Looks at Cardiovascular Risks in COVID-19 Survivors 8. Penumbra Launches Indigo System CAT RX Catheter in Europe to Address Acute Coronary Syndrome 4. In Memoriam: Bruce Wilkoff, MD, FHRS 5.
7-9, and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health. 7-9, and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health. Data was unavailable for the remaining 34 participants mainly due to the COVID-19 pandemic.
Stroke, Volume 55, Issue Suppl_1 , Page A58-A58, February 1, 2024. Multivariable logistic models were used to evaluate the differences in mortality between patients admitted from April to December 2020, with and without COVID-19, and those admitted during a similar period in 2019. 2.51; SAH: 2.76, 1.68-4.54), 4.16; SAH: 5.77, 1.57-21.17).
Introduction COVID-19 may lead to long-term endothelial consequences including hypertension, stroke and myocardial infarction. A pilot study ‘COVID-19 blood pressure endothelium interaction study’, which found that patients with normal blood pressure (BP) at the time of hospital admission with COVID-19 showed an 8.6
During the COVID-19 pandemic, the American Heart Association created a new 2024 Impact Goal with health equity at its core, in recognition of the increasing health disparities in our country and the overwhelming evidence of the damaging effect of structural racism on cardiovascular and stroke health. Circulation, Ahead of Print.
Stroke, Volume 55, Issue Suppl_1 , Page AWP52-AWP52, February 1, 2024. Background:Shortly after AHA/ASA released an updated policy on stroke care systems, COVID-19 disrupted these systems. As a result, telehealth expanded rapidly across Texas. Audiotapes were transcribed, and files prepared for analysis.
The American Stroke Association, a division of the American Heart Association. The American Stroke Association, a division of the American Heart Association. This study shows that people with stroke can also benefit from high-intensity interval training,” said Kevin Moncion, Ph.D., Click here to access the article.
The paper that was brought to my attention is one that purports to examine the deleterious health effects of Long COVID. A sizable group of intellectuals who are still socially distancing and wearing n95s live in fear of a syndrome that persists long after a person recovers from COVID. The notable exception was loss of smell).
Stroke, Volume 56, Issue Suppl_1 , Page AWMP117-AWMP117, February 1, 2025. Introduction:SARS-CoV-2 causes various neurological sequelae in COVID-19 survivors including fatigue and cognitive dysfunction. Endothelial dysfunction, a key mechanism in COVID-19 illness, is also a major risk factor for vascular dementia (VaD).
Stroke, Ahead of Print. BACKGROUND:Many national initiatives focus on promoting early hospital arrival of patients with acute ischemic stroke (AIS) because treatment effectiveness is time-dependent. However, several studies reported time-delays in hospital arrival, especially during the COVID-19 pandemic. LKWA >4.5
Stroke, Volume 55, Issue Suppl_1 , Page AWP240-AWP240, February 1, 2024. Background:Individuals with poorly controlled blood pressure (BP) have a heightened risk of stroke and vascular cognitive impairment. BP reduction has been associated with reduced risk of future stroke and cognitive impairment.
Stroke, Volume 56, Issue 1 , Page 209-218, January 1, 2025. Telemedicine for stroke (Telestroke) has been a key component to efficient, widespread acute stroke care for many years. Some Telestroke practitioners have not had fellowship-level vascular neurology training and many are without training specific to virtual modalities.
COVID-19 likely increases relative risk (RR (95% CI)) of myocardial infarction (3.3 (1.0 to 11.0)), stroke (3.5 (1.2 COVID-19 likely increases relative risk (RR (95% CI)) of myocardial infarction (3.3 (1.0 to 11.0)), stroke (3.5 (1.2 to 4.9)) and stroke (2.6 (95% Most studies had a high risk of bias.
Stroke, Volume 55, Issue Suppl_1 , Page A118-A118, February 1, 2024. Background:Persistent post-stroke impairment of the arm and hand is debilitating after stroke. Data was available from 74 participants at one year, with others not available mainly due to COVID-19.Results:At p<0.001) and 0.51±0.52
Results The trial was discontinued early by the funder due to slow recruitment during the COVID-19 pandemic. The incidence of stroke and major bleeding was similar. The primary outcome was a composite of all-cause mortality, new myocardial infarction or hospitalisation for heart failure at 12 months. hours (IQR: 0.9–2.0))
Stroke, Volume 55, Issue Suppl_1 , Page ATP265-ATP265, February 1, 2024. Introduction:Recent trials have shown the benefit of PFO closure in recurrent stroke prevention. There is no standardized practice to dictate appropriate AC/AP therapy in the setting of stroke secondary to PFO prior to closure.
Stroke, Volume 55, Issue Suppl_1 , Page ATP80-ATP80, February 1, 2024. There is evidence to suggest that MA stroke patients are less likely to receive inpatient rehabilitation facility (IRF) based care in favor of home health. of the 16,231 stroke discharges, respectively. Changes in 2020 were likely attributed to COVID-19.
Stroke, Volume 56, Issue Suppl_1 , Page AWP400-AWP400, February 1, 2025. SARS-COV-2 causes neurological and cognitive impairments and aggravates Alzheimers Disease-Related Dementia (ADRD). Yet, the molecular mechanism is not fully understood. Cerebral hypoxia was confirmed by laser speckle imaging.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionMission Thrombectomy, established in 2016 by the Society of Vascular and Interventional Neurology, aims to enhance global accessibility to mechanical thrombectomy surgery for strokes caused by large vessel occlusion in the brain.
Hybrid Conference’ : ‘The RNA vaccines against COVID-19 mark the beginning of a technological revolution that will transform the way we treat disease and restore health. Maybe I should just attend this meeting ‘ The New Frontier of RNA Nanotherapeutic. Monday, October 24, 2022 8:30 a.m. – 5 p.m.
Stroke, Volume 55, Issue Suppl_1 , Page ATP314-ATP314, February 1, 2024. This approach may be pivotal in reducing both acute and chronic neurological morbidities associated with COVID-19.
Also, the technology helps in stroke detection by enabling the software to find large vessel occlusions that can further cause a stroke. The reports are immediately sent to the stroke team so that appropriate action can be taken in time.
Research Highlights: An analysis of UK Biobank health data that included adults who had mild to severe COVID-19 before vaccines were available found an increased risk of heart attack, stroke and death among those adults during the nearly three-year.
At study entry, 38% of the patients were taking sodium glucose cotransporter 2 (SGLT2) inhibitors or glucagon-like peptide-1 receptor agonists (GLP-1 RAs), medications for diabetes that have been shown to have beneficial effects on heart disease, including reducing heart failure, heart attacks and strokes.
An analysis of data in the UK Biobank has found that COVID-19 infection may increase the risk of heart attack, stroke and death from any cause for up to three years for people with and without cardiovascular disease, according to new research.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content